- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04152044
Obesity and Liver Function in Oesophageal Cancer
November 2, 2019 updated by: Noel Edward Donlon, St. James's Hospital, Ireland
Elucidating the Role of Obesity, Liver Function and Pathology With Overall Outcomes in Oesophageal Cancer
There is an established link between sarcopenia and outcomes in oesophageal cancer.
There is scant reports in the literature regarding the influences of different obesity in different compartments.
Study Overview
Status
Unknown
Conditions
Detailed Description
Oesophageal cancer rates are increasing as a result of obesity in Western society.
Thr investigators are evaluating the influence of viscerala dn subcutaneous obesity on overall outcomes of the participants.
In addition the investigators are evaluating if there is a correlation with Liver Function Tests and liver histopathology such as steatosis on survival in participants and post operative sequele.
Study Type
Observational
Enrollment (Anticipated)
658
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
IE
-
Dublin, IE, Ireland, D8
- Recruiting
- St. James's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
oesophageal cancer patients
Description
Inclusion Criteria:
- Those undergoing oesophagectomy
Exclusion Criteria:
- patients who only had chemotherapy/chemoradiotherapy without surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Liver biopsy, Visceral and subcutaneous obesity
Those with histology and LFT's and quantificaiton of obesity
|
Patinets undergoing surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Overall Survival
Time Frame: 1 year
|
1 year
|
Disease free survival
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 1, 2019
Primary Completion (ANTICIPATED)
July 1, 2020
Study Completion (ANTICIPATED)
November 1, 2020
Study Registration Dates
First Submitted
November 2, 2019
First Submitted That Met QC Criteria
November 2, 2019
First Posted (ACTUAL)
November 5, 2019
Study Record Updates
Last Update Posted (ACTUAL)
November 5, 2019
Last Update Submitted That Met QC Criteria
November 2, 2019
Last Verified
November 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SJH00003
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Observation of different types of obesity and liver pathology in patients undergoing and oesophagectomy
-
Herning HospitalKolding SygehusCompleted
-
University Hospital Schleswig-HolsteinCharite University, Berlin, Germany; German Federal Ministry of Education and... and other collaboratorsRecruiting
-
West Virginia UniversityCompletedStatus Post Total Hip and Knee Arthroplasty
-
Assistance Publique Hopitaux De MarseilleRecruitingParkinson DiseaseFrance
-
University Hospital, Basel, SwitzerlandRecruitingAnterior Cruciate Ligament (ACL) InjurySwitzerland
-
Hangzhou Tangji Medical Technology Co., Ltd.Not yet recruitingNonalcoholic Fatty Liver Disease
-
Wayne State UniversityRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
PerspectumActive, not recruitingLiver Cancer | Liver Metastasis Colon CancerUnited Kingdom
-
Yunus EmreNot yet recruitingSedation Complication | Magnetic Resonance Imaging Contrast Media Adverse Reaction